Raltegravir-d3 Potassium Salt |
|
| Synonyms: N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide-d3 Potassium Salt; | |
| Cat. No.: R11571 | CAS No.: 1246816-98-7 /871038-72-1(unlabelled) |
| MDL.: | Formula: C20H17D3FKN6O5 |
| F.W.485.53 | Purity: 99％ |
| Storage: -20°C Freezer | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 1mg | POA | Enter qty and click checkbox |
| Catalog Number： | R11571 | CAS No.: | 1246816-98-7 /871038-72-1(unlabelled) | |
| MDL: | Formula: | C20H17D3FKN6O5 | ||
| F.W.: | 485.53 | Purity: | 99％ | |
| Package: | Unit: | mg | ||
| Appearance: | Off-White to Pale Brown Solid | M.P.: | 252-255°C | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | DMSO, Methanol | Stability: | ||
| Storage: | -20°C Freezer | Category: | Reference Standard | |
| Reference: | Wade, K., et al.: J. Pharmacol. Biomed. Anal., 8, 401 (1990), Hazuda, D., et al.: Science, 287, 646 (2000), Williams, J., et al.: Drug Metab. Dispos., 32, 1201 (2004), Duckett, C., et al.: Xenobiotica, 36, 59 (2006), Miners, J., et al.: Biochem. Pharmacol | |||
| Application: | A potent human immunodeficiency virus (HIV) integrase inhibitor. A novel anti-AIDS drug. | |||
| Category: | Inhibitors, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals, | |||